![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, August 16, 2020 1:30:19 PM
So they seem like the deep pockets here ...similar to the Baker Bros who helped fund Amarin's Reduce it trial in 2015 at around a $1 a share ( ran as high as $25 on FDA approval years later ) .
The current trials are not very large or expensive and the Chairman of the board maintains " we have sufficient access to capital to fund these studies on our own ".
Stock needs to trade above $4 to be listed on the NYSE or Naz ...I see no need for the Co to do a reverse split anytime soon if they can fund completion of the trials with existing access lines to capital ...and partner for the production scale up of RLF-100 and for distribution to hospitals .
Kiwi
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM